Clinical trial design and management

Research output: Contribution to journalArticlepeer-review

Abstract

The randomised, controlled trial (RTC) is considered the gold standard for the assessment of the effect of any therapeutic intervention. However, rare diseases carry several issues in terms of population size, life-threatening nature of the condition and lack of other available treatments, which basically render this approach not always feasible. Alternative methodological approaches are being developed to better suit the need of an orphan drug development.

Original languageEnglish
Pages (from-to)57-62
Number of pages6
JournalPharmaceuticals Policy and Law
Volume12
Issue number1-2
DOIs
Publication statusPublished - 2010

Keywords

  • controlled trial
  • population size
  • Randomised
  • rare disorder

ASJC Scopus subject areas

  • Health Policy
  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Fingerprint Dive into the research topics of 'Clinical trial design and management'. Together they form a unique fingerprint.

Cite this